Zydus Lifesciences gets approval from USFDA for generic drug
Image Credit: money control
Zydus Lifesciences on Friday said it has received approval from the US health regulator to market Estradiol Transdermal System, used to treat moderate to severe symptoms of menopause, in the American market. The drug firm has received final approval from the US Food and Drug Administration (USFDA) to market the drug in multiple strengths, the company said in a regulatory filing.